Horizon Therapeutics PLC (HZNP)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Timothy P. Walbert
Employees:
1,950
CONNAUGHT HOUSE, 1ST FLOOR, 1 BURLINGTON ROAD, DUBLIN, IRELAND 4
011-353-1-772-2100

Horizon Therapeutics Public Limited Company focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation.

Data derived from most recent annual or quarterly report
Market Cap 24.754 Billion Shares Outstanding226.621 Million Avg 30-day Volume 1.75 Million
P/E Ratio47.5161 Dividend Yield0.0 EPS0.59
Price to Revenue7.8716 Debt to Equity0.5503 EBITDA902.83 Million
Price to Book Value5.4355 Operating Margin16.8338 Enterprise Value26.384 Billion
Current Ratio3.158 EPS Growth0.254 Quick Ratio2.496
1 Yr BETA 0.8391 52-week High/Low 117.49 / 57.84 Profit Margin16.5661
Operating Cash Flow Growth86.3044 Altman Z-Score4.6991 Free Cash Flow to Firm -2.087 Billion
Earnings Report2023-05-03
View SEC Filings from HZNP instead.

View recent insider trading info

Horizon Therapeutics PLC YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding HZNP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HZNP

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-14 by THOMPSON ELIZABETH H.Z.
  • 4: filed on 2023-03-06 by CLAYTON SEAN M.
  • 4: filed on 2023-03-06 by DESJARDIN MICHAEL A.
  • 4: filed on 2023-01-18 by SHERMAN JEFFREY W
  • 4: filed on 2023-01-18 by PASTERNAK ANDY
  • 4: filed on 2023-01-12 by SHERMAN JEFFREY W
  • 4: filed on 2023-01-06 by MCILVENNY PATRICK
  • 4: filed on 2023-01-06 by SHERMAN JEFFREY W
  • 4: filed on 2023-01-06 by DESJARDIN MICHAEL A.
  • 4: filed on 2023-01-06 by WALBERT TIMOTHY P

    • Events (8k)

  • 8-K: filed on 2023-03-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-24:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
  • 8-K: filed on 2023-01-31:
    Item 8.01: Other Events
  • 8-K: filed on 2022-12-12:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-29:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-07:
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2022-08-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-02:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    18.5 Thousand total shares from 3 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    THOMPSON ELIZABETH H.Z. EVP, RESEARCH & DEVELOPMENT

    • Officer
    		 14,575 2023-03-13 6

    DESJARDIN MICHAEL A. EVP, TECHNICAL OPERATIONS

    • Officer
    		 126,558 2023-03-02 5

    CLAYTON SEAN M. EVP, GENERAL COUNSEL

    • Officer
    		 8,121 2023-03-01 3

    SHERMAN JEFFREY W EVP AND CHIEF MEDICAL OFFICER

    • Officer
    		 236,645 2023-01-17 7

    PASTERNAK ANDY EVP, CHIEF STRATEGY OFFICER

    • Officer
    		 56,338 2023-01-17 8

    COX AARON EVP, CHIEF FINANCIAL OFFICER

    • Officer
    		 277 2023-01-13 5

    WALBERT TIMOTHY P CHAIRMAN, PRESIDENT AND CEO

    • Officer
    • Director
    		 912,333 2023-01-04 13

    MCILVENNY PATRICK CHIEF ACCOUNTING OFFICER

    • Officer
    		 23,821 2023-01-04 2

    HIMAWAN JEFF

    • Director
    		 54,833 2022-12-30 2

    LEONARDI JACOPO PRES., GLOBAL COMMERCIAL OPS

    • Officer
    		 44,466 2022-06-01 2

    GREY MICHAEL G

    • Director
    		 65,374 2022-04-28 1

    SANTINI GINO

    • Director
    		 72,609 2022-04-28 1

    WATKINS THOMAS

    • Director
    		 91,164 2022-04-28 1

    MAHONY SUSAN

    • Director
    		 16,617 2022-04-28 1

    SHANNON JAMES SAMUEL

    • Director
    		 42,910 2022-04-28 1

    DANIEL WILLIAM F

    • Director
    		 77,551 2022-04-28 1

    WITZ PASCALE

    • Director
    		 43,917 2022-04-28 1

    HOELSCHER PAUL W. EVP, CFO

    • Officer
    		 176,935 2022-04-20 3

    MOZE BARRY EVP, CHIEF ADMIN. OFFICER

    • Officer
    		 182,954 2022-01-05 0

    MCHUGH MILES W SR VP & PRINC. ACCTG OFFICER

    • Officer
    		 67,044 2022-01-04 0

    BEELER BRIAN K EVP, GENERAL COUNSEL

    • Officer
    		 62,775 2021-09-17 0

    KENT JEFF SEE REMARKS

    • Officer
    		 126,994 2021-05-11 0

    CAMARDO DANIEL A. EVP AND PRESIDENT, U.S.

    • Officer
    		 58,955 2021-04-05 0

    CURTIS GEOFFREY M. EVP, CORPORATE AFFAIRS, CCO

    • Officer
    		 53,095 2021-04-01 0

    KARNANI VIKRAM EVP & PRESIDENT, INTERNATIONAL

    • Officer
    		 104,165 2021-02-22 0

    KONSTANTINOVSKY IRINA EVP, CHIEF HUMAN RESOURCES OFF

    • Officer
    		 81,677 2021-02-22 0

    ROSEN KARIN EVP, R&D & CSO

    • Officer
    		 0 2021-01-04 0

    LIN SHAO-LEE EVP, HEAD OF R&D AND CSO

    • Officer
    		 109,668 2020-01-21 0

    PAULI RONALD

    • Director
    		 33,600 2019-05-02 0

    CAREY ROBERT EVP, CHIEF BUSINESS OFFICER

    • Officer
    		 266,358 2019-03-23 0

    WALBERT TIMOTHY P CHAIRMAN, PRESIDENT AND CEO

    WALBERT TIMOTHY P CHAIRMAN, PRESIDENT AND CEO

    • Officer
    • Director
    		 680,757 2019-01-04 13

    HAMPTON GEORGE P EVP, PRIMARY CARE BUS. UNIT

    • Officer
    		 41,473 2018-04-01 0

    MOSBROOKER ERIC SVP, ORPHAN BUSINESS UNIT

    • Officer
    		 3,585 2017-11-01 0

    HAPPEL DAVID EVP, COMMERCIAL DEV & STRATEGY

    • Officer
    		 5,089 2017-10-25 0

    NOHRIA VIRINDER

    • Director
    		 No longer subject to file 2017-05-03 0

    ACKERMAN TIMOTHY J. SVP, COMMERCIAL OPERATIONS

    • Officer
    		 41,129 2017-01-10 0

    THOMAS JOHN B EVP, CORPORATE STRATEGY AND IR

    • Officer
    		 7,620 2016-05-06 0

    KELLY DAVID GEORGE EVP, COMPANY SECRETARY

    • Officer
    		 145,138 2016-03-23 0

    KODY JOHN J EVP, CHIEF COMMERCIAL OFFICER

    • Officer
    		 12,766 2015-11-24 0

    VENKATARAMAN BALAJI

    • FORMER 10% OWNER
    		 No longer subject to file 2014-11-13 0

    DE VAERE ROBERT J EVP & CFO

    • Officer
    		 No longer subject to file 2014-09-30 0

    VIDARA THERAPEUTICS HOLDINGS LLC

    • 10% Owner
    • FORMER 10% OWNER
    		 No longer subject to file 2014-09-22 0

    SMITH TODD N EVP, CHIEF COMMERCIAL OFFICER

    • Officer
    		 No longer subject to file 2014-09-19 0

    BIRD JEFFREY W

    • Director
    		 3,028,304 2013-12-13 0

    ADATTO MICHAEL SVP, MANAGED CARE & COMM. DEV.

    • Officer
    		 64,461 2012-12-31 0

    QUAKER BIOVENTURES II LP

    • 10% Owner
    		 3,516,009 2012-10-09 0

    FORMELA JEAN FRANCOIS

    • Director
    • 10% Owner
    		 No longer subject to file 2012-03-02 0

    ATLAS VENTURE FUND VI LP

    ATLAS VENTURE FUND VI GMBH & CO KG

    ATLAS VENTURE ASSOCIATES VI, L.P.

    ATLAS VENTURE ENTREPRENEURS FUND VI LP

    • 10% Owner
    		 No longer subject to file 2012-03-02 0

    ESSEX WOODLANDS HEALTH VENTURES FUND VII LP

    • 10% Owner
    		 5,755,100 2012-03-02 0

    ATLAS VENTURE FUND VI LP

    ATLAS VENTURE ASSOCIATES VI, INC

    ATLAS VENTURE ENTREPRENEURS FUND VI LP

    ATLAS VENTURE FUND VI GMBH & CO KG

    • 10% Owner
    		 5,393,178 2011-08-02 0

    SCALE VENTURE PARTNERS II, LP

    SCALE VENTURE MANAGEMENT II, LLC

    MITCHELL KATE

    O'DRISCOLL RORY

    WIENBAR SHARON L

    • 10% Owner
    		 2,266,631 2011-08-02 0

    BOCK LOUIS C

    • Director
    		 2,222,750 2011-08-02 0

    JOHANN PETER

    • Director
    		 5,949,694 2011-08-02 0

    BIRNER HUBERT

    • Director
    		 967,467 2011-08-02 0

    NGN BIOMED OPPORTUNITY I GMBH & CO. BETEILIGUNGS KG

    NGN BIOMED OPPORTUNITY I L P

    • 10% Owner
    		 123,287 2011-07-28 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    THOMPSON ELIZABETH H.Z. - Officer EVP, RESEARCH & DEVELOPMENT

    		2023-03-14 16:45:22 -0400 2023-03-13 G 2,000 d 14,575 direct 0.1005 0.1005 2 0.0 1

    DESJARDIN MICHAEL A. - Officer EVP, TECHNICAL OPERATIONS

    		2023-03-06 16:48:47 -0500 2023-03-02 M 743 $17.19 a 126,558 direct -0.1455 -0.2364 0.0728 4 -0.4638 5

    DESJARDIN MICHAEL A. - Officer EVP, TECHNICAL OPERATIONS

    		2023-03-06 16:48:47 -0500 2023-03-02 M 743 d 0 direct

    DESJARDIN MICHAEL A. - Officer EVP, TECHNICAL OPERATIONS

    		2023-03-06 16:48:47 -0500 2023-03-02 M 3,629 $14.93 a 125,815 direct -0.1455 -0.2364 0.0728 4 -0.4638 5

    DESJARDIN MICHAEL A. - Officer EVP, TECHNICAL OPERATIONS

    		2023-03-06 16:48:47 -0500 2023-03-02 M 3,629 d 0 direct

    CLAYTON SEAN M. - Officer EVP, GENERAL COUNSEL

    		2023-03-06 16:52:11 -0500 2023-03-01 F 7,032 $110.34 d 7,376 direct -0.1455 -0.2364 0.0728 4 -0.4638 5

    CLAYTON SEAN M. - Officer EVP, GENERAL COUNSEL

    		2023-03-06 16:52:11 -0500 2023-03-01 M 14,129 a 14,408 direct -0.1455 -0.2364 0.0728 4 -0.4638 5

    CLAYTON SEAN M. - Officer EVP, GENERAL COUNSEL

    		2023-03-06 16:52:11 -0500 2023-03-01 M 14,129 a 28,258 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 20:45:03 UTC 4.32 0.25 4200000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 20:15:04 UTC 4.32 0.25 4200000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 19:45:04 UTC 4.32 0.25 4200000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 19:15:03 UTC 4.32 0.25 4200000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 18:45:03 UTC 4.3091 0.2609 4200000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 18:15:05 UTC 4.3091 0.2609 4200000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 17:45:03 UTC 4.3091 0.2609 4200000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 17:15:04 UTC 4.3091 0.2609 4200000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 16:45:03 UTC 4.32 0.25 4100000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 16:15:04 UTC 4.32 0.25 4100000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 15:45:03 UTC 4.32 0.25 4000000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 15:15:03 UTC 4.32 0.25 4000000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 14:45:03 UTC 4.32 0.25 4000000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 14:15:03 UTC 4.32 0.25 4000000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 13:45:04 UTC 4.32 0.25 4000000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 13:15:03 UTC 4.32 0.25 4000000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-22 12:45:03 UTC 4.32 0.25 4000000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-21 22:15:04 UTC 4.32 0.25 4000000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-21 21:45:03 UTC 4.32 0.25 4000000
    HORIZON THERAPEUTICS PLC HZNP 2023-03-21 21:15:03 UTC 4.32 0.25 4000000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Jackson Variable Series Trust- JNL/Nicholas Convertible Arbitrage Fund HZNP -19350.0 shares, $-573147.0 2020-03-31 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund HZNP -94.0 shares, $-2784.28 2020-03-31 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund HZNP -2600.0 shares, $-295880.0 2022-12-31 N-PORT

    Congressional Transactions Past 6-Months

    To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***
    Congress Person Party Chamber Filing Filing Date Transaction Date Security Type Owner Transaction Amount
    Hon. Daniel Goldman House Filing 2023-02-09 2023-01-31 S $15,001-$50,000

    Elevate your investments